CSIMarket



Eli Lilly And Company  (LLY)
Other Ticker:  
 
 

LLY's EPS Net Growth by Quarter and Year

Eli Lilly And's EPS Net results by quarter and year




LLY EPS Net (in $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 1.89 2.31 1.64
III Quarter September - 1.22 1.33 1.37
II Quarter June - 1.53 1.55 1.44
I Quarter March 2.10 1.49 1.60 4.31
FY   2.10 6.13 6.79 8.76



LLY EPS Net first quarter 2022 Y/Y Growth Comment
Eli Lilly And Company achieved in the first quarter 2022, above Company average EPS Net rise of 40.94% year on year, to $ 2.10 .

Looking into first quarter 2022 results within Major Pharmaceutical Preparations industry 8 other companies have achieved higher EPS Net growth. While Eli Lilly And Company' s EPS Net jump of 40.94% ranks overall at the positon no. 476 in the first quarter 2022.




LLY EPS Net ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - -18.18 % 40.85 % 429.03 %
III Quarter September - -8.27 % -2.92 % 22.32 %
II Quarter June - -1.29 % 7.64 % -
I Quarter March 40.94 % -6.88 % -62.88 % 271.55 %
FY   - -9.72 % -22.49 % 274.36 %

Financial Statements
Eli Lilly And's first quarter 2022 EPS Net $ 2.10 LLY's Income Statement
Eli Lilly And's first quarter 2021 EPS Net $ 1.49 Quarterly LLY's Income Statement
New: More LLY's historic EPS Net Growth >>


LLY EPS Net (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - 54.92 % 73.68 % 19.71 %
III Quarter September - -20.26 % -14.19 % -4.86 %
II Quarter June - 2.68 % -3.13 % -66.59 %
I Quarter March 11.11 % -35.5 % -2.44 % 1290.32 %
FY (Year on Year)   - -9.72 % -22.49 % 274.36 %




EPS Net first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #9
Healthcare Sector #29
Overall #476

EPS Net Y/Y Growth Statistics
High Average Low
134.69 % 4.23 % -36.78 %
(Mar 31 2019)   (Sep. 30. 2008)
EPS Net first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #9
Healthcare Sector #29
Overall #476
EPS Net Y/Y Growth Statistics
High Average Low
134.69 % 4.23 % -36.78 %
(Mar 31 2019)   (Sep. 30. 2008)

EPS Net by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Eli Lilly And's Q/Q EPS Net Growth


EPS Net Q/Q Growth Statistics
High Average Low
1296.14 % 24.43 % -100 %
(Mar 31 2019)  


LLY's I. Quarter Q/Q EPS Net Comment
Eli Lilly And Company achieved in the I. Quarter 2022 below company average EPS Net rise of 11.11% quarter on quarter, to $ 2.10 .

I. Quarter 2022 Eli Lilly And's EPS Net sequential growth appear to be a mixed bag, even if beneath the average, yet it demonstrates absolute improvement measured to the -35.5% in the same quarter a year ago Oliver  T. Jones, Healthcare sector contributor situated in London said.

Within Major Pharmaceutical Preparations industry 11 other companies have achieved higher EPS Net quarter on quarter growth. While Eli Lilly And's EPS Net growth quarter on quarter, overall rank is 539.


EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #12
Healthcare Sector #30
Overall #539
EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #12
Healthcare Sector #30
Overall #539
EPS Net Q/Q Growth Statistics
High Average Low
1296.14 % 24.43 % -100 %
(Mar 31 2019)  


LLY's I. Quarter Q/Q EPS Net Comment
Eli Lilly And Company achieved in the I. Quarter 2022 below company average EPS Net rise of 11.11% quarter on quarter, to $ 2.10 .

I. Quarter 2022 EPS Net sequential growth seem to be a mixed bag, even if beneath the ordinary rise of 24.43 %, yet it presents a quite improvement measured to the -35.5% in the I. Quarter a year ago Oliver  T. Jones, Healthcare sector contributor situated in London said.

Within Major Pharmaceutical Preparations industry 11 other companies have achieved higher EPS Net quarter on quarter growth. While Eli Lilly And's EPS Net growth quarter on quarter, overall rank is 539.


Eli Lilly And's 12 Months EPS Net Growth Year on Year


EPS Net TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative EPS Net 12 Months Ending $ 6.74 $ 6.13 $ 6.55 $ 6.66 $ 6.68
Y / Y EPS Net Growth (TTM) 0.89 % -9.73 % 7.04 % 8.13 % 10.43 %
Year on Year EPS Net Growth Overall Ranking # 982 # 641 # 1218 # 1217 # 856
Seqeuential EPS Net Change (TTM) 9.95 % -6.42 % -1.65 % -0.3 % -1.62 %
Seq. EPS Net Growth (TTM) Overall Ranking # 476 # 1683 # 1375 # 1646 # 1452




Cumulative EPS Net growth Comment
Although Eli Lilly And's Annual EPS Net growth year on year were below company's average 42.16% , EPS Net announced in the Mar 31 2022 period, show improvement in EPS Net trend, to cumulative trailing twelve month growth of 0.89% year on year, from -9.73% in Dec 31 2021.

In the Healthcare sector 61 other companies have achieved higher trailing twelve month EPS Net growth. While EPS Net growth total ranking has deteriorated compare to previous quarter from 641 to 982.

EPS Net TTM Q/Q Growth Statistics
High Average Low
134.69 %
4.23 %
-36.78 %
 

EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 9
Healthcare Sector # 62
Overall # 982

EPS Net TTM Y/Y Growth Statistics
High Average Low
1580.68 %
42.16 %
-79.01 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry # 9
Sector # 29
S&P 500 # 476
Cumulative EPS Net growth Comment
Although Eli Lilly And's Annual EPS Net growth year on year were below company's average 42.16% , EPS Net announced in the Mar 31 2022 period, show improvement in EPS Net trend, to cumulative trailing twelve month growth of 0.89% year on year, from -9.73% in Dec 31 2021.

In the Healthcare sector 61 other companies have achieved higher trailing twelve month EPS Net growth. While EPS Net growth total ranking has deteriorated compare to previous quarter from 641 to 982.

EPS Net TTM Q/Q Growth Statistics
High Average Low
134.69 %
4.23 %
-36.78 %
 


EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 9
Healthcare Sector # 62
Overall # 982

EPS Net TTM Y/Y Growth Statistics
High Average Low
1580.68 %
42.16 %
-79.01 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry # 9
Sector # 29
S&P 500 # 476




Other EPS Net Growth
Major Pharmaceutical Preparations Industry EPS Net Growth Trends and Statistics
Healthcare Sector EPS Net Growth Statistics
EPS Net Growth Trends for overall market
LLY's EPS Net Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS Net Growth
Lowest Ranking EPS Net Growth
EPS Net Growth for LLY's Competitors
EPS Net Growth for Eli Lilly And's Suppliers
EPS Net Growth for LLY's Customers

You may also want to know
LLY's Annual Growth Rates LLY's Profitability Ratios LLY's Asset Turnover Ratio LLY's Dividend Growth
LLY's Roe LLY's Valuation Ratios LLY's Financial Strength Ratios LLY's Dividend Payout Ratio
LLY's Roa LLY's Inventory Turnover Ratio LLY's Growth Rates LLY's Dividend Comparisons



Companies with similar EPS Net rise for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %EPS Net for the quarter ending Mar 31 2022
Catalyst Pharmaceuticals Inc 71.43%$ 71.429 
Becton Dickinson And Company59.57%$ 59.574 
Repligen Corp55.77%$ 55.769 
Iqvia Holdings Inc 54.13%$ 54.128 
Conmed Corporation51.61%$ 51.613 
Charles River Laboratories International inc 50.83%$ 50.833 
Medpace Holdings Inc 48.25%$ 48.246 
Phibro Animal Health Corp46.67%$ 46.667 
Abcellera Biologics Inc 45.95%$ 45.946 
Prestige Consumer Healthcare Inc 44.99%$ 44.992 
Tenet Healthcare Corp42.22%$ 42.222 
Eli Lilly And Company40.94%$ 40.940 
Abbott Laboratories37.00%$ 37.000 
Merck and Co Inc 36.00%$ 36.000 
Bio techne Corp32.14%$ 32.143 
Co diagnostics Inc 30.77%$ 30.769 
Abbvie Inc 26.13%$ 26.131 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

GSAQ's Profile

Stock Price

GSAQ's Financials

Business Description

Fundamentals

Charts & Quotes

GSAQ's News

Suppliers

GSAQ's Competitors

Customers & Markets

Economic Indicators

GSAQ's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071